Suppr超能文献

[c-erbB-2 阳性和阴性乳腺癌的形态计量学评估及核仁组成区嗜银蛋白数量:无相关性]

[Morphometric evaluation and AgNOR number in c-erbB-2 positive and negative breast carcinoma: absence of correlation].

作者信息

Leopardi O, Caronni E, Zucchi A, Colecchia M, Dedé A

机构信息

Servizio di anatomia ed istologia patologica, Ospedale Maggiore di Lodi (USSL 56).

出版信息

Pathologica. 1993 Mar-Apr;85(1096):163-73.

PMID:8103213
Abstract

A total of 722 nuclei from 22 fine needle aspirates (FNA) of breast carcinomas have been subjected to quantitative nuclear analysis. Form Factor, Nuclear Area and Nuclear Major Diameter were determined for each case. An equal number of nuclei from as many aspirates from benign breast nodules was used as control. The aim of the study was to evaluate the predictive value of these parameters on the result of the immunohistochemical determination of the c-erb B-2 antigen in the tumour mass, since 6 of the 22 carcinomas were positive to this antigen. None of these parameters singly or in combination proved of any value in predicting the positive or negative result of the c-erb B-2 antigen determination. Nuclei both positive and negative for the antigen were located within the large cell carcinomas. Nucleolar Organizer Regions were also determined on the histologic sections of both groups to assess any statistically significant difference not only between controls and carcinomas, but also between c-erb B-2 positive and negative cases. Both NOR mean numbers and NOR cytograms were of no use, since no difference was found between c-erb B-2 positive and negative cases.

摘要

对22例乳腺癌细针穿刺抽吸物(FNA)中的722个细胞核进行了定量核分析。测定了每例的形态因子、核面积和核长径。从良性乳腺结节的抽吸物中选取同样数量的细胞核作为对照。本研究的目的是评估这些参数对肿瘤块中c-erb B-2抗原免疫组化测定结果的预测价值,因为22例癌中有6例对该抗原呈阳性。这些参数单独或联合使用均未显示出对预测c-erb B-2抗原测定的阳性或阴性结果有任何价值。抗原阳性和阴性的细胞核均位于大细胞癌内。还在两组的组织学切片上测定了核仁组成区,以评估不仅对照与癌之间,而且c-erb B-2阳性和阴性病例之间是否存在任何统计学上的显著差异。核仁组成区平均数量和核仁组成区细胞图谱均无用处,因为在c-erb B-2阳性和阴性病例之间未发现差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验